[Double-blind study on the effects of mepartricin (SPA-S-160) versus placebo in the treatment of obstruction caused by adenoma of the prostate].
Rizzo
M
M
Tosto
A
A
Dattolo
E
E
Serni
S
S
D000368:Aged; D000369:Aged, 80 and over; D004311:Double-Blind Method; D004341:Drug Evaluation; D006801:Humans; D008297:Male; D008613:Mepartricin / Q000627:therapeutic use*; D008875:Middle Aged; D011090:Polyenes / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy*; D014524:Urethral Obstruction / Q000209:etiology* / Q000503:physiopathology; D014563:Urodynamics
D011090:Polyenes; D008613:Mepartricin
Studio in doppio cieco sugli effetti della mepartricina (SPA-S-160) verso placebo nel trattamento dell'ostruzione da adenoma della prostata.